Physician

Diane Krane Laber, M.D.

According to 2025 Medicare claims, Diane Laber, M.D. (NPI: 1932299625) practices allergy/immunology in the Pinehurst-Southern Pines, NC market, with the plurality of this provider's patient population coming from Moore, NC. This provider's primary affiliated billing organization is ALLERGY PARTNERS, PLLC (NPI: 1447241435; TIN: 561249571) and primary practice location at 28374-8850. Laber is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Laber's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 388 traditional Medicare patients, billed 21,545 HCPCS/CPT codes, and received $320,689 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,237 prescription claims across 260 beneficiaries totaling $1,701,463 in drug costs, led by Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50). DME data shows 212 claims. Open Payments data shows 48 records totaling $1,388. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $206,342 to $320,689. Similarly, Part D prescription costs have moved sharply higher in recent years, from $163,057 to $1,701,463. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $3,409 to $6,182.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$225K$450K2015 Medicare payment: $206,342 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $211,342 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $201,570 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $133,407 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $190,215 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $245,813 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $383,788 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $450,197 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $347,909 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $320,689 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201534416,539$206,342
201636016,977$211,342
201741017,827$201,570
201837714,324$133,407
201942116,990$190,215
202035115,742$245,813
202141220,609$383,788
202243526,576$450,197
202339823,364$347,909
202438821,545$320,689

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$851K$1.7M2015 Drug cost: $163,057 (USD; Tot_Drug_Cst)2016 Drug cost: $307,809 (USD; Tot_Drug_Cst)2017 Drug cost: $300,623 (USD; Tot_Drug_Cst)2018 Drug cost: $268,516 (USD; Tot_Drug_Cst)2019 Drug cost: $383,180 (USD; Tot_Drug_Cst)2020 Drug cost: $480,015 (USD; Tot_Drug_Cst)2021 Drug cost: $760,489 (USD; Tot_Drug_Cst)2022 Drug cost: $1,420,715 (USD; Tot_Drug_Cst)2023 Drug cost: $1,599,477 (USD; Tot_Drug_Cst)2024 Drug cost: $1,701,463 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152111,043$163,057
20162561,477$307,809
20172691,424$300,623
20182431,330$268,516
20192731,427$383,180
20202881,712$480,015
20213111,634$760,489
20222971,455$1,420,715
20232731,310$1,599,477
20242601,237$1,701,463

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$239K$478K2015 Medicare payment: $141,871 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $219,208 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $115,132 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $151,203 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $268,648 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $337,115 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $371,062 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $477,608 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $476,303 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $397,314 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R67$141,871
2016N/R109$219,208
2017N/R73$115,132
2018N/R135$151,203
2019N/R276$268,648
2020N/R220$337,115
2021N/R228$371,062
2022N/R239$477,608
2023N/R242$476,303
2024N/R212$397,314

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more102102$116
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more229331$85
95165Professional service for preparation and provision of 1 or more antigens1522,750$10
95117Professional service for multiple injections of allergen1251,379$8
96160Administration and interpretation of patient-focused health risk assessment216327$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
HizentraImmun Glob G(Igg)/Pro/Iga 0-50441,232$396,090
Dupixent PenDupilumab722,128$290,480
XolairOmalizumab882,394$287,835
CuvitruImmun Glob G(Igg)/Gly/Iga Ov5028770$211,748
RinvoqUpadacitinib12360$79,490

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1559Injection, immune globulin (hizentra), 100 mgNN/R62$324,979
J1555Injection, immune globulin (cuvitru), 100 mgNN/R13$66,582
A4221Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)NN/R64$4,643
K0552Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, eachNN/R73$1,111

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.48$1,388AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Diane Krane Laber, M.D.?

Tedicare shows public-source Medicare data for Diane Krane Laber, M.D. (NPI 1932299625), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Diane Krane Laber, M.D. have ACO affiliation data?

Diane Krane Laber, M.D. is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Diane Krane Laber, M.D.?

Diane Krane Laber, M.D. is linked to ALLERGY PARTNERS, PLLC (billing NPI 1447241435) in the available physician profile data.

Does Diane Krane Laber, M.D. have Open Payments data?

Diane Krane Laber, M.D. has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.